Global Fertility Supplements Market, By Ingredient (Synthetic/Blend of Natural & Synthetic, Natural), By Product (Capsules, Tablets, Soft Gels, Powder, Liquids, Other Products), By Distribution Channel (OTC, Prescribed, Other Distribution Channels), By End-User (Women, Men), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The Global Fertility Supplements Market size is expected to be worth around USD 3.95 Billion by 2032 from USD 1.92 Billion in 2022, growing at a CAGR of 7.69% during the forecast period from 2023 to 2032.

The main drivers of the market’s expansion are the rising infertility rate and the increase in the number of fertility clinics. Other significant components that influence market expansion include changing lifestyles, increasing technological developments in the healthcare industry, and rising product innovations. The market for fertility supplements is also growing as a result of women’s delayed pregnancy and ongoing fertility rate decline.

The market for fertility supplements made to promote reproductive health and enhance fertility in both men and women is referred to as the fertility supplement market. Due to the COVID-19 virus being discovered to have an effect on a person’s degree of fertility, the COVID-19 pandemic had a positive effect on the market for fertility supplements.

The increase in smokers, which has resulted in decreased fertility rates, as well as an increase in consumption of alcohol and caffeine are anticipated to drive market growth in the upcoming years.

Key Takeaways

• Market Size: Expected to grow from USD 1.92 billion in 2022 to USD 3.95 billion by 2032, at a CAGR of 7.69%.
• Growth Drivers: Rising infertility rates, expansion of fertility clinics, and lifestyle changes are major factors boosting market growth.
• COVID-19 Impact: The pandemic increased interest in fertility supplements due to potential impacts of the virus on fertility levels.
• Leading Segment: Synthetic ingredients dominate with over 85% revenue share, driven by demand for substances like folic acid and zinc.
• Product Preference: Capsules lead the product types with over 40% market share in 2022, favored for their convenience and nutrient protection.
• Distribution Leadership: Over-the-counter products hold over 75% market share, benefiting from accessibility and less stringent regulations.
• Prescription Growth: The prescribed segment is projected to expand at a CAGR of 10.8% from 2022 to 2030.
• Regional Dominance: North America leads the market with a 37% share, driven by high awareness and prevalent fertility issues.
• Fastest Growing Region: Asia Pacific expected to grow at an 11.0% CAGR through 2030, driven by enhanced healthcare access and investment.
• Consumer Trends: Increasing preference for natural and organic fertility supplements reflects a shift towards healthier, sustainable choices.

Ingredient Analysis

The synthetic segment held the highest revenue share more than 85.0%. The main synthetic substances that contributed considerably to overall expansion because of growing demand and simple availability are folic acids, selenium, vitamin C, vitamin B6, zinc, and myoinositol. The natural segment is expected to grow significantly between 2022 and 2030, at a CAGR of 10.0%.

In the upcoming years, it is anticipated that the market for natural fertility supplements will expand owing to the launch of new products and technological advancements in the wellness and health industry. The demand is expected to rise in the coming years as individuals use increased amounts of plant-based products to maintain a healthy lifestyle and reduce their chance of suffering from negative effects.

Product Analysis

In 2022, the capsules market held the highest share, which was above 40.0%. Due to rising consumer awareness of the nutritional benefits that these products offer, as well as their delightful flavors and simplicity of use in meals, the powder segment is anticipated to grow at a CAGR of 10.2% over the forecasting period. These products facilitate the new ingredient combinations, reduce gastrointestinal irritation, protect against sensitive ingredients, and ensure oil as well as fat-soluble nutrient delivery.

This aspect is anticipated to help segment expansion. The high costs of the blister packaging technique, however, are expected to discourage manufacturers from using capsule formulation throughout the anticipated timeframe. In 2022, the tablet market segment expanded to become the second-largest product market segment. High-quality supplement excipients enhance tablet absorption.

Distribution Channel Analysis

The over-the-counter distribution segment is dominated by the largest market share of more than 75%. Owing to increasing demand, easy access to raw resources as well as lenient regulations. Companies that expect to remain relevant in this highly competitive sector must focus on using FDA-regulated ingredients that have gone through a significant number of clinical trials or studies. Self-medication for the treatment of fertility issues is one of the major trends in the OTC segment.

Additionally, manufacturers of OTC fertility supplements would benefit from features including cost-effectiveness and ease of direct purchasing, it is anticipated that in the coming years. From 2022-2030, it is anticipated that the prescribed segment will expand at a sustainable CAGR of 10.8%. Additionally, during the duration of the forecast period, there is predicted to be an increase in demand for prescribed fertility supplements due to increasing spending on research and development as well as support from both the private and public sectors.

End-User Analysis

The women segment held the largest share of over 55.0%. They are often the main focus of products promoted to increase fertility, women are an important end-user segment for fertility supplements. Women who are trying to conceive may use fertility supplements to support their menstrual cycle, enhance egg quality, or increase their chances of ovulation. Women who are undergoing fertility treatments may also use supplements to support their overall reproductive health.

Key Market Segments

By Ingredient

• Synthetic/Blend of Natural & Synthetic
• Natural

By Product

• Capsules
• Tablets
• Soft Gels
• Powder
• Liquids
• Other Products

By Distribution Channel

• OTC
• Prescribed
• Other Distribution Channels

By End-User

• Women
• Men

Drivers

Rising demand for natural fertility treatments

Many couples who are trying to conceive are seeking natural alternatives to conventional medical treatments such as IVF. Fertility supplements are seen as safe improve chances of conception and natural way to support fertility.

Growing awareness of the benefits of preconception care

Preconception care, which is making efforts to improve health and fertility before trying to conceive, is becoming increasingly popular among couples. Fertility supplements are seen as an important part of preconception care, as they can provide the body with key nutrients that are needed for healthy fertility.

Restraints

There are also several key restraints such as Limited scientific evidence, Regulatory challenges, Price sensitivity, and Limited consumer awareness. Many fertility supplements are promoted as natural and safe, yet there is limited scientific evidence to back their efficacy.

However, regulations in some regions could make it difficult for businesses to promote and sell these products. Fertility supplements can be expensive compared with other dietary supplements. Though awareness of fertility supplements is growing, some consumers may still not be aware of their benefits or be skeptical of their effectiveness. This could restrict market expansion.

Opportunities

The fertility supplement market presents a major opportunity for businesses in the healthcare and wellness sectors, as well as investors looking to capitalize on increasing demand for natural, holistic approaches to fertility. However, it is important to note that the efficacy of fertility supplements can vary widely, and consumers should exercise caution when choosing and using these products.

In addition, new growth prospects in the market for fertility supplements are anticipated as a result of technical developments like the creation of personalized nutrition and the use of artificial intelligence in the supplement sector.

Latest Trends

Growing consumer demand for natural and organic supplements

To support their reproductive health, consumers are increasing their preference for natural and organic vitamins. Increased awareness of the potential risks linked to supplements made of synthetic materials or chemicals that are driving this trend.

Male fertility supplements

There is an increasing demand for supplements targeted at male fertility, as male infertility is a significant issue that affects a large percentage of the population. The creation of new supplements designed exclusively to promote male reproductive health is being driven by this trend.

Demand for Natural and Organic Supplements

Consumers are growing in preference for natural and organic supplements to support their reproductive health as they become more aware of potential risks linked with supplements derived from synthetic or chemical-based products. This trend can be attributed to increasing awareness of such potential risks.

Regional Analysis

The fertility supplements market was led by North America in 2022 with a share of 37%. Due to the enormous number of healthcare and wellness businesses, the high level of consumer awareness, and the significant prevalence of fertility problems, North America has the largest market for fertility supplements. Owing to variables such as a high rate of infertility, increasing desire for natural and organic products, and a robust regulatory environment, the U.S. has the largest market in the region.

Between 2022 and 2030, Asia Pacific is expected to grow at a significant CAGR of 11.0%. Due to the improved accessibility and availability of healthcare facilities as well as the increased spending in the research and healthcare sectors, the area presents lucrative potential for leading firms in the fertility supplement market.

Key Regions and Countries

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Manufacturers are focusing on improving the treatment experience and success rates. Companies such as TTK HealthCare, Orthomol, and Fairhaven Health are focusing on expanding and innovating their product portfolios to help people who want to conceive. Companies are continuing to advance fertility supplement innovation in order to increase success rates through life cycle management, which includes new combinations and new indications.

Leading fertility supplement manufacturers are focusing on developing new products by investing in R&D and technological advancement to provide cost-effective, high-quality products that match the market trends such as non-GMO and organic. Industry participants are also involved in joint ventures, mergers & acquisitions, and partnerships to expand their market share as well as geographical reach.

Market Key Players

• Lenus Pharma GesmbH
• Active Bio Life Science GmbH
• Orthomol
• Exeltis USA, Inc.
• PregPrep LLC
• Bionova
• Vitabiotics Ltd.
• TTK Healthcare Ltd.
• Fertility Nutraceuticals LLC
• Extreme V, Inc.
• VH Nutrition LLC
• CellOxess LLC
• Gonadosan
• Amino Expert (Innovamed Ltd.)
• Babystart Ltd.
• Crown Nutraceuticals
• YadTech
• Other Key Players

Recent Developments

• In April 2022, Ovaterra by Fertility Nutraceuticals released two new prenatal vitamins. These capsules provide the entire recommended daily value for choline for nursing and pregnant women and come in individual doses that can be taken on the go.
• In February 2022, EMD Serono, a healthcare company of Merck KGaA, introduced Slim Pack fertility medication packaging. This new design is smaller and more efficient while still having minimal environmental and health impacts. This launch aims to enhance portability, efficiency, convenience, and speed.

Report Scope